Narrow search
Showing 1 - 10 of 1,917
Cover Image
The impact of the entry of biosimilars : evidence from Europe
Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - 2017
Persistent link: https://www.econbiz.de/10011708133
Cover Image
Evaluating the US pharmaceutical patent policy
Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Cover Image
Principles of pharmacoeconomics
Bootman, J. Lyle (ed.); Townsend, Raymond J. (contributor);  … - 1996 - 2. ed.
Persistent link: https://www.econbiz.de/10000563687
Cover Image
Pharmaceutical price regulation : public perceptions, economic realities, and empirical evidence
Vernon, John A.; Golec, Joseph - 2008
Persistent link: https://www.econbiz.de/10003779330
Cover Image
Essentials of pharmacoeconomics
Rascati, Karen L. - 2009
Persistent link: https://www.econbiz.de/10003530457
Cover Image
Spatial dynamics of public pharmaceutical expenditure
Lauridsen, Jørgen; Bech, Mickael; López, Fernando; … - In: Case studies in business, industry and government … 1 (2006/2007) 1, pp. 80-90
Persistent link: https://www.econbiz.de/10003966436
Cover Image
Vaccine marketing
Angelmar, Reinhard; Morgon, Pierre A. - 2012
Persistent link: https://www.econbiz.de/10009572811
Cover Image
Why brand drugs priced higher than generic equivalents
Iacocca, Kathleen; Sawhill, James; Zhao, Yao - In: International journal of pharmaceutical and healthcare … 9 (2015) 1, pp. 3-19
Persistent link: https://www.econbiz.de/10011302283
Cover Image
Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?
Hemphill, Thomas A. - In: Innovation: organization & management : IOM 15 (2013) 3, pp. 364-367
Persistent link: https://www.econbiz.de/10010226637
Cover Image
The determinants of pricing in pharmaceuticals : are US prices really so high?
Cabrales, Antonio; Jiménez-Martín, Sergi - In: Health economics 22 (2013) 11, pp. 1377-1397
Persistent link: https://www.econbiz.de/10010242974